{"The establishment of the Clinton Health Access Initiative in 2002": "which aimed to lower the cost of HIV/AIDS drugs through bulk-buying and consolidation of supply and bidding processes.", "The World Health Organization": "s report in 2014, stating that by the end of 2013, over 11.7 million people in low- and middle-income countries were on antiretroviral therapy, indicating increased access to HIV/AIDS medicine.", "The decrease in the price of individual antiretroviral formulations over the past decade": "as reported by the WHO, with median costs falling from about $600 in 2003 to about $100 a decade later.", "The Clinton Foundation": "s role in tracking drug prices and assisting health departments around the world in negotiating with drug companies, as part of their efforts to improve access to affordable HIV/AIDS medicine."}